Q1 2026 Holdings
Filed 2026-05-14 | 450 holdings | $362.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gladstone Invt Corp(GAIN) | COM | 376546107 | $582.7K | 41,033 | 0.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $583.7K | 20,840 | 0.2% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $600.9K | 219,293 | 0.2% |
| Sound Point Meridian Cap Inc(SPMC) | COMMON STOCK | 83617A108 | $600.9K | 67,142 | 0.2% |
| Pennantpark Floating Rate CA(PFLT) | COM | 70806A106 | $603.1K | 75,014 | 0.2% |
| Horizon Technology FIN Corp(HRZN) | COM | 44045A102 | $606.1K | 143,968 | 0.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $607.3K | 16,721 | 0.2% |
| Carlyle Secured Lending Inc(CGBD) | COM | 872280102 | $609.6K | 55,723 | 0.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $610.1K | 29,163 | 0.2% |
| Cion Invt Corp(CION) | COM | 17259U204 | $611.6K | 89,408 | 0.2% |
| Golub Cap BDC Inc(GBDC) | COM | 38173M102 | $612.3K | 48,365 | 0.2% |
| Midcap Financial Invstmnt Co(MFIC) | COM NEW | 03761U502 | $620.6K | 55,212 | 0.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $634.0K | 16,173 | 0.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $644.2K | 57,986 | 0.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $646.5K | 7,434 | 0.2% |
| Invesco SR Income TR(VVR) | COM | 46131H107 | $654.2K | 203,173 | 0.2% |
| Runway Growth Finance Corp(RWAY) | COM | 78163D100 | $665.4K | 96,849 | 0.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $671.6K | 82,610 | 0.2% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $684.2K | 37,824 | 0.2% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $685.4K | 29,092 | 0.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $691.6K | 22,940 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $692.2K | 31,095 | 0.2% |
| New MTN FIN Corp(NMFC) | COM | 647551100 | $694.3K | 89,471 | 0.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $700.4K | 4,283 | 0.2% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $708.5K | 14,894 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $720.1K | 24,239 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $727.7K | 5,524 | 0.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $728.0K | 10,378 | 0.2% |
| Oaktree Specialty Lending(OCSL) | COM | 67401P405 | $729.8K | 64,582 | 0.2% |
| FS KKR Cap Corp(FSK) | COM | 302635206 | $735.3K | 72,227 | 0.2% |
| Pennantpark Invt Corp(PNNT) | COM | 708062104 | $743.3K | 165,540 | 0.2% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $754.1K | 46,464 | 0.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $755.2K | 12,045 | 0.2% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $760.3K | 11,160 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $772.6K | 1,476 | 0.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $784.3K | 10,445 | 0.2% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $785.8K | 2,646 | 0.2% |
| Goldman Sachs BDC Inc(GSBD) | SHS | 38147U107 | $788.0K | 88,738 | 0.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $789.4K | 53,267 | 0.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $791.4K | 8,904 | 0.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $814.4K | 135,954 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $834.2K | 11,234 | 0.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $853.3K | 39,213 | 0.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $876.0K | 3,830 | 0.2% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $877.1K | 13,571 | 0.2% |
| Prospect Cap Corp(PSEC) | COM | 74348T102 | $882.0K | 337,946 | 0.2% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $885.7K | 20,651 | 0.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $888.8K | 4,848 | 0.2% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $889.0K | 4,453 | 0.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $890.9K | 3,449 | 0.2% |